Menu
Search

News

Swiss Deep Tech News & Analysis

Stay informed on the Swiss technology landscape. This is your central resource for Deep Tech News, combining key developments from across the ecosystem with original, data-driven analysis from the Deep Tech Nation Foundation. We track and report on significant technological milestones, funding rounds, and research to provide a comprehensive overview for international investors, partners, and researchers.

Curated Newsfeed

See all news

DTN Highlights

See DTN Highlights

  • Cradle raises $73m to accelerate adoption of AI-powered protein engineering

    Cradle, the leading platform for AI-powered protein engineering based in Amsterdam and Zurich, has raised $73m in Series B funding to respond to rising demand…

    startupticker.ch

    • Cradle raised $73M in Series B funding to scale its AI platform for protein engineering, reducing time and costs across pharma, chemicals, and food.
    • Cradle expanded partnerships with Novo Nordisk and Ginkgo Bioworks, growing its customer base across pharma, chemicals, food, agriculture, and materials.
    • Cradle will expand its wet lab for training data and hire engineers to improve machine learning capabilities for complex protein handling.
    startupticker.ch: Cradle raises $73m to accelerate adoption of AI-powered protein engineering

  • USD16.7 million to expand Kyan Health’s workplace wellness platform globally

    Using predictive analytics, Kyan helps companies including Hitachi Energy, Hilti, STADA, Deutsche Börse Group, and On to monitor and reduce risks like absenteeism, turnover, and…

    startupticker.ch

    • Kyan Health raised $16.7M to improve workplace mental health using AI-powered preventive care and organizational insights.
    • On achieved 50% employee engagement and $2.9M annual value (11.6x ROI) using Kyan's platform for mental health.
    • Kyan's AI navigator personalizes employee resources while maintaining privacy through encryption and aggregated employer insights.
    startupticker.ch: USD16.7 million to expand Kyan Health’s workplace wellness platform globally

  • Zitadel raises $9 million Series A

    Zitadel, the leading provider of cloud-native identity infrastructure solutions, has today announced its $9 million Series A funding round led by Nexus Venture Partners with…

    startupticker.ch

    • Zitadel raised $9M Series A from Nexus Venture Partners to expand its cloud-native identity infrastructure platform.
    • Open-source platform offers developer APIs, multi-tenant architecture, and data ownership control for hybrid and multi-cloud environments.
    • Zitadel serves 160+ customers across manufacturing, finance, healthcare, and SaaS sectors seeking customizable authentication solutions.
    startupticker.ch: Zitadel raises $9 million Series A

  • Toronto-based company acquires Nanoleq and Osmotex

    Myant Corp., a leader in textile computing and AI-integrated healthcare solutions, has acquired Nanoleq and Osmotex, Switzerland’s leading textile computing companies. This strategic partnership brings…

    startupticker.ch

    • Myant acquired Swiss textile firms Nanoleq and Osmotex to expand AI healthcare solutions across Europe and Middle East from Zurich.
    • Nanoleq's Oxa device uses textile sensors to track respiration, ECG, heart rate variability, and stress for home health monitoring.
    • Osmotex's electronic breathable membrane enables moisture control for protective gear, wound healing, and drug delivery applications.
    startupticker.ch: Toronto-based company acquires Nanoleq and Osmotex

  • $25M to speed LocalStack Enterprise Cloud Development Vision

    LocalStack just raised $25 million in Series A funding led by Notable Capital, with participation from existing investors CRV and Heavybit. This milestone marks a…

    startupticker.ch

    • LocalStack raised $25M Series A to expand its local AWS development platform with Snowflake and Azure emulator support.
    • LocalStack cuts local AWS environment testing from 28 minutes to 24 seconds, significantly accelerating development cycles.
    • LocalStack serves 8M weekly sessions and 900+ paying customers, adding chaos engineering and state snapshotting features.
    startupticker.ch: $25M to speed LocalStack Enterprise Cloud Development Vision

  • TeamViewer backs RealWear’s acquisition of Almer Technologies

    In a move set to reshape the industrial Augmented Reality (AR) market, RealWear, the global leader in wearable computing for industrial applications, today announced its…

    startupticker.ch

    • RealWear acquired Swiss AR headset maker Almer Technologies to combine rugged voice-operated devices with lightweight AR headsets for industrial workers.
    • Almer's subscription AR model and design complement RealWear's brand and distribution to create an industrial AR market leader.
    • TeamViewer maintains its investor role while clients like Coca-Cola HBC and Ford show significant efficiency gains from the combined solution.
    startupticker.ch: TeamViewer backs RealWear’s acquisition of Almer Technologies

  • Fintech startup Wyden secures $16.9 million to fuel global expansion

    Wyden, the leader in institutional infrastructure for the digital asset trading lifecycle, announces the closing of its USD 16.9 million (CHF 14.5 million) Series B…

    startupticker.ch

    • Wyden raised $16.9M in Series B funding led by Truffle Capital to expand its digital asset trading infrastructure globally.
    • Wyden plans to integrate 20 additional banks, brokers and exchanges by 2025 while expanding its team to 100 professionals.
    • Wyden targets regulated markets in EU, Switzerland, Turkey, UAE, Singapore, Hong Kong and Brazil with its trade lifecycle platform.
    startupticker.ch: Fintech startup Wyden secures $16.9 million to fuel global expansion

  • Alentis Therapeutics raises $181.4 million in oversubscribed series D round

    Focusing on the development of treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, Alentis Therapeutics has secured $181.4 million in Series D financing round…

    startupticker.ch

    • Alentis Therapeutics raised $181.4M in Series D funding for CLDN1-targeted antibody-drug conjugates treating solid tumors and organ fibrosis.
    • FDA cleared IND for ALE.P02 Phase 1/2 trial in CLDN1+ squamous tumors, with clinical trials expected to start Q1 2025.
    • Company plans two first-in-human trials in 2025 targeting the CLDN1 pathway with different payload mechanisms.
    startupticker.ch: Alentis Therapeutics raises $181.4 million in oversubscribed series D round

  • $4.3 million to accelerate people-sensing technology for human-machine interaction

    Algorized, an AI-powered platform pioneering advanced people-sensing and positioning software, has raised $4.3 million in seed funding to drive innovation in people sensing and support…

    startupticker.ch

    • Algorized raised $4.3M in seed funding from Amazon Industrial Innovation Fund for AI-powered people-sensing software.
    • The company's sensor-agnostic software transforms existing wireless sensors into accurate people-detection without hardware upgrades.
    • Algorized's edge-processed ML algorithms enable disaster rescue and workplace safety in robotics environments.
    startupticker.ch: $4.3 million to accelerate people-sensing technology for human-machine interaction

  • Swiss start-up scene tops patent rankings

    The European Patent Office (EPO) has carried out a study to identify the universities from which start-ups use research results. Three Swiss universities made it…

    startupticker.ch

    • European universities' patent applications rose from 6% in 2000 to over 10% in 2019, with 12% filed by startups.
    • ETH Zurich, EPFL, and University of Zurich rank among Europe's top 12 universities for startup innovation.
    • Switzerland leads Europe with 74.2 deep tech startups per million inhabitants with patents, outpacing Sweden and UK.
    startupticker.ch: Swiss start-up scene tops patent rankings

  • Monte-Rosa Therapeutics enters billion-dollar partnership with Novartis

    Monte Rosa Therapeutics, a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced a global license agreement with Novartis. Under the terms…

    startupticker.ch

    • Novartis licensed Monte Rosa's VAV1-directed molecular glue degraders, paying $150M upfront plus up to $2.1B in milestones.
    • MRT-6160 is an oral drug showing promise in preclinical models for multiple sclerosis, rheumatoid arthritis, and IBD.
    • Monte Rosa co-funds Phase 3 development and shares U.S. profits; Novartis leads Phase 2 and global commercialization.
    startupticker.ch: Monte-Rosa Therapeutics enters billion-dollar partnership with Novartis

  • $10 million to make web3 data accessible

    Born global with a team spread across the globe, Validation Cloud is a leading Web3 data and AI company. Its staking product has more than…

    startupticker.ch

    • Validation Cloud raised $10M led by True Global Ventures to expand its AI product for Web3 data accessibility.
    • The company's staking product exceeded $1 billion in assets with 400% year-over-year growth.
    • Validation Cloud combines staking, node API, and AI to compress blockchain data exploration from hours to seconds.
    startupticker.ch: $10 million to make web3 data accessible